Skepticism: A lost clinical art

Clinical Infectious Diseases

Volumn 31, Issue 2, 2000, Pages 513-518

  DiNubile, M J ^a  

^a Education Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; FLUCONAZOLE; METRONIDAZOLE; PEFLOXACIN; PLACEBO; ZIDOVUDINE;

ACUTE HEMORRHAGIC PANCREATITIS; ATTITUDE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CONTROLLED STUDY; DRUG RESEARCH; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL PRACTICE; MYCOSIS; PHYSICIAN; PRIORITY JOURNAL; RESPONSIBILITY; REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VIRUS LOAD;

CLINICAL COMPETENCE; COMMUNICABLE DISEASES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PATIENT CARE MANAGEMENT;

EID: 0034458016     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313945     Document Type: Review

References (72)

1. Acute necrotizing pancreatitis
2. Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis
3. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem
4. The role of antibiotic prophylaxis in severe acute pancreatitis
5. Empirical evidence of design-related bias in studies of diagnostic tests
6. Problems in the design reporting of trials of antifungal agents encountered during meta-analysis
7. The placebo effect: An interdisciplinary exploration
8. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
9. Guidelines for clinical guidelines
10. Guidelines in general practice the new Tower of Babel?
11. The N.I.H. "E-biomed" proposal: A potential threat to the evaluation and orderly dissemination of new clinical studies
12. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
13. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. US Department of Health and Human Services and the Henry J, Kaiser Family Foundation
14. Antiretroviral therapy for HIV infection in adults: Updated recommendations of the International AIDS Society-USA Panel
15. Debating dual AIDS guidelines
16. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
17. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel
18. Drug resistance genotyping in HIV-1 therapy: The VIRADAPT randomized controlled trial
19. Role of transthoracic and transesophageal echocardiography in diagnosis and management of infective endocarditis
20. Diagnosis and management of infective endocarditis and its complications
21. A negative transthoracic echocardiogram obviates the need for transesophageal echocardiography in patients with suspected native valve active infective endocarditis
22. Echocardiography in patients with suspected endocarditis: A cost-effectiveness analysis
23. 1998 Guidelines for treatment of sexually transmitted diseases
24. Lumbar puncture in asymptomatic late syphilis: An analysis of the benefits and risks
25. Failure of prophylaxis for bacterial endocarditis: American Heart Association registry
26. Epidemiology of bacterial endocarditis in the Netherlands. II. Antecedent procedures and use of prophylaxis
27. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis
28. A quantitative assessment of pre-dental anti-biotic prophylaxis for patients with mitral-valve prolapse
29. Endocarditis prophylaxis for patients with mitral valve prolapse: A quantitative analysis
30. Dental and cardiac risk factors for infective endocarditis: A population-based, case-control study
31. Infective endocarditis and dentistry: Outcome-based research
32. Dentists are innocent! "Everyday" bacteremia is the real culprit: A review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children
33. Drug therapy: Prevention of infective endocarditis
34. Antibiotics for prevention of endocarditis during dentistry: Time to scale back?
35. Should all patients with candidemia be treated with antifungal agents?
36. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
37. Hospital-acquired fungemia: Its natural course and clinical significance
38. A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B
39. Surrogate end points in clinical trials: Are we being misled?
40. Validating surrogate markers - Are we being naive?
41. A pilot study of the short-term effects of antiretroviral management based on plasma genotypic antiretroviral resistance testing (GART) in patients failing antiretroviral therapy [abstract LB-8]. CPCRA 046 Study Team
42. Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World
43. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries
44. USA outlines standard of care for HIV/AIDS
45. Prevention of vertical transmission of HIV: Analysis of cost effectiveness of options available in South Africa
46. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting
47. Beyond H.I.V. viral load testing
48. Preventing perinatal transmission of human immunodeficiency virus in the United States. Committee on Perinatal Transmission of HIV
49. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
50. CD4 cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
51. Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy
52. Genotypic or phenotypic susceptibility testing may not predict clinical responses to indinavir
53. High baseline HIV-1 viral load is associated with CD4 recovery in the absence of full virologic suppression
54. A pressure to agree
55. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography
56. Valve ring abscess in active infective endocarditis: Frequency, location and clues to clinical diagnosis from the study of 95 necroscopy patients
57. Cardiac conduction abnormalities complicating native valve active infective endocarditis
58. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: Experience in 103 patients
59. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia
60. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up
61. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users
62. Hospital-acquired candidemia: The attributable mortality and excess length of stay
63. Nosocomial candidemia: Risk factors and attributable mortality
64. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient
65. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
66. Candidemia in intensive care unit patients: Risk factors for mortality
67. Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
68. Empiric antifungal therapy in febrile granulocytopenic patients
69. "Evidence-based," "cost-effective" and "preference-driven" medicine: Decision analysis based medical decision making is the prerequisite
70. Responsibility for patient care: Where does the buck stop?